Biocon is a pharmaceutical company founded in India with a major aim to find ways to treat cancer, diabetes, and autoimmune ...

What is the time of Sehri today in Bangalore ? Today Sehri time in Bangalore is 05:24. What is the time to eat Sehri? Today 05:24 is time to eat Sehri. What is the time of Sehri and Iftar in Bangalore ...

Sharing on social media, Salman Khan was seen flaunting this Rs 61 lakh watch. (Image: Instagram) As Salman Khan returns to the big screen after nearly two years in Nadiadwala production, Sikandar ...

Bangalore streets covered in white foam (Image Source: Instagram/milanfied) A video has surfaced on social media, sparking curiosity among residents about the white foam that covered Bangalore streets ...

Or the heads of the global MNCs in India – Bhushan Akshikar from GSK, an MNC with a 100-year history in India and Amitabh Dube from Novartis among others. That the evening was engaging was ...

Karnataka Bandh On March 22nd: Kannada Okkuta, an umbrella organisation representing various pro-Kannada groups, has called for the Bandh (statewide shutdown) on Saturday, March 22 to protest the ...

A corporate worker moved from Noida to Bengaluru for a better salary but regrets the decision due to poor infrastructure, heavy traffic, and cultural differences. The high population density, poor ...

Story continues below this ad Transport unions: Associations representing Karnataka State Road Transport Corporation (KSRTC) and Bangalore Metropolitan Transport Corporation (BMTC) employees have ...

On Wednesday, Novartis gave a more detailed look at long-awaited clinical data that the company believes will help secure a broad approval for a successor drug to its blockbuster gene therapy ...

Basel, March 20, 2025 – Novartis today announced that oral Fabhalta ® (iptacopan) has received U.S. Food and Drug Administration (FDA) approval for the treatment of adults with C3 glomerulopathy (C3G) ...

No­var­tis re­leased two Phase 3 datasets on Wednes­day that show a new ver­sion of its gene ther­a­py Zol­gens­ma led to mo­tor func­tion im­prove­ments in pa­tients … ...

A pair of clinical data sets gives Novartis confidence in a new formulation of the company’s gene therapy Zolgensma for the treatment of older patients with spinal muscular atrophy (SMA).